Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatment efficacy in UGT1A128 polymorphism carriers

Academic Article

Publication Date:

2012

Iris type:

01.01 Articolo in rivista

Keywords:

HIV; pharmacogenetics; hyperbilirubinaemia; antiretroviral therapy; therapeutic drug monitoring

List of contributors:

Authors of the University:

ADORNI FULVIO DANIELE

Handle:

Published in:

Journal